While many studies demonstrate the mutations of KDM6A and KDM6B in cancers and suggest a tumor-suppressive function of these two demethylases [130–135], several studies show KDM6A and KDM6B may exhibit oncogenic activity [136, 137]. This evidence concerns the gene MBD2 and cancer.